Last year's massive mobilization underscores how besieged the industry felt over complaints about soaring medicine prices and high profits. PhRMA's $271 million in revenue for the year represented its biggest budget since 2009, when it recorded $350 million in dues and other revenue. The $57 million it spent on lobbying was also the most since 2009, when the lobbying bill was $70 million.